Research ArticleOriginal Article
Open Access

Sociodemographic and clinical predictors of refractory type 2 diabetes patients

Findings from a case-control study

Turki J. Alharbi, Ayla M. Tourkmani, Abdulaziz Bin Rsheed, Abood F. Al Abood and Yasser K. Alotaibi
Saudi Medical Journal February 2021, 42 (2) 181-188; DOI: https://doi.org/10.15537/smj.2021.2.25694

References

  1. 1.↵
    1. Aronson R.
    The functionally refractory patient in diabetes—prevalence and predictors within specialist care registries. US Endocrinology 2015; 11: 30-31.
    OpenUrl
  2. 2.↵
    1. Aronson R,
    2. Orzech N,
    3. Ye C,
    4. Goldenberg R,
    5. Brown V.
    Specialist‐led diabetes registries and predictors of poor glycemic control in type 2 diabetes: Insights into the functionally refractory patient from the LMC Diabetes Registry database. J Diabetes 2016; 8: 76-85.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Leiter LA,
    2. Berard L,
    3. Bowering CK,
    4. Cheng AY,
    5. Dawson KG,
    6. Ekoé JM, et al.
    Type 2 diabetes mellitus management in Canada: is it improving? Can J Diabetes 2013; 3: 82-89.
    OpenUrl
  4. 4.
    1. Borgermans L,
    2. Goderis G,
    3. Van Den Broeke C,
    4. Verbeke G,
    5. Carbonez A,
    6. Ivanova A, et al.
    Interdisciplinary diabetes care teams operating on the interface between primary and specialty care are associated with improved outcomes of care: findings from the Leuven Diabetes Project. BMC Health Serv Res 2009; 9: 179.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Clement M,
    2. Harvey B,
    3. Rabi DM,
    4. Roscoe RS,
    5. Sherifali D.
    Organization of diabetes care. Can J Diabetes 2013; 37: S20-S25.
    OpenUrl
  6. 6.↵
    1. Riddle MC,
    2. Ambrosius WT,
    3. Brillon DJ,
    4. Buse JB,
    5. Byington RP,
    6. Cohen RM, et al.
    Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care 2010; 33: 983-990.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Alqurashi KA,
    2. Aljabri KS,
    3. Bokhari SA.
    Prevalence of diabetes mellitus in a Saudi community. Ann Saudi Med 2011; 31: 19-23.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Al-Rubeaan KA,
    2. Youssef AM,
    3. Subhani SN,
    4. Ahmad NA,
    5. Al-Sharqawi AH,
    6. Ibrahim HM.
    A Web-based interactive diabetes registry for health care management and planning in Saudi Arabia. J Med Internet Res 2013; 15: e202.
    OpenUrl
  9. 9.↵
    1. Shah BR,
    2. Hux JE,
    3. Laupacis A,
    4. Mdcm BZ,
    5. Austin PC,
    6. Van Walraven C.
    Diabetic patients with prior specialist care have better glycaemic control than those with prior primary care. J Eval Clin Pract 2005; 11: 568-575.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Shorr RI,
    2. Franse LV,
    3. Resnick HE,
    4. Di Bari M,
    5. Johnson KC,
    6. Pahor M.
    Glycemic control of older adults with type 2 diabetes: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Am Geriatr Soc 2000; 48: 264-267.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Toh MPHS,
    2. Wu CX,
    3. Leong HSS.
    Association of younger age with poor glycemic and cholesterol control in Asians with type 2 Diabetes Mellitus in Singapore. J Endocrinol Metab 2011; 1: 27-37.
    OpenUrl
  12. 12.↵
    1. Bruce D,
    2. Davis W,
    3. Davis T.
    Glycemic control in older subjects with type 2 diabetes mellitus in the Fremantle Diabetes Study. J Am Geriatr Soc 2000; 48: 1449-1453.
    OpenUrlPubMedWeb of Science
  13. 13.↵
    1. Rothenbacher D,
    2. Ruter G,
    3. Saam S,
    4. Brenner H.
    Younger patients with type 2 diabetes need better glycaemic control: results of a community-based study describing factors associated with a high HbA1c value. Br J Gen Pract 2003; 53: 389-391.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Glasgow RE,
    2. Hampson SE,
    3. Strycker LA,
    4. Ruggiero L.
    Personal-model beliefs and social-environmental barriers related to diabetes self-management. Diabetes care 1997; 20: 556-561.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. El-Kebbi IM,
    2. Cook CB,
    3. Ziemer DC,
    4. Miller CD,
    5. Gallina DL,
    6. Phillips LS.
    Association of younger age with poor glycemic control and obesity in urban African Americans with type 2 diabetes. Arch Intern Med 2003; 163: 69-75.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Song S,
    2. Hardisty C.
    Early onset type 2 diabetes mellitus: a harbinger for complications in later years-clinical observation from a secondary care cohort. QJM 2009; 102: 799-806.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Benoit SR,
    2. Fleming R,
    3. Philis-Tsimikas A,
    4. Ji M.
    Predictors of glycemic control among patients with type 2 diabetes: a longitudinal study. BMC public health 2005; 5: 36.
    OpenUrlCrossRefPubMed
  18. 18.
    1. Valle T,
    2. Koivisto VA,
    3. Reunanen A,
    4. Kangas T,
    5. Rissanen A.
    Glycemic control in patients with diabetes in Finland. Diabetes Care 1999; 22: 575-579.
    OpenUrlAbstract
  19. 19.↵
    1. Verma M,
    2. Paneri S,
    3. Badi P,
    4. Raman P.
    Effect of increasing duration of diabetes mellitus type 2 on glycated hemoglobin and insulin sensitivity. Indian J Clin Biochem 2006; 21: 142.
    OpenUrl
  20. 20.↵
    1. Juarez DT,
    2. Sentell T,
    3. Tokumaru S,
    4. Goo R,
    5. Davis JW,
    6. Mau MM.
    Factors associated with poor glycemic control or wide glycemic variability among diabetes patients in Hawaii, 2006-2009. Prev Chronic Dis 2012; 9: 120065.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Group UPDS.
    Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Mullugeta Y,
    2. Chawla R,
    3. Kebede T,
    4. Worku Y.
    Dyslipidemia associated with poor glycemic control in type 2 diabetes mellitus and the protective effect of metformin supplementation. Indian J Clin Biochem 2012; 27: 363-369.
    OpenUrlCrossRefPubMed
  23. 23.
    1. Mohammadi H,
    2. Abdelouahed E,
    3. Hassar M,
    4. Bouchrif B,
    5. Qarbal B,
    6. Dahbi F, et al.
    Glycaemic control, HbA1c, and lipid profile in children with type 1 diabetes mellitus. Eur J Sci Res 2009; 29: 289-294.
    OpenUrl
  24. 24.↵
    1. Khan HA.
    Clinical significance of HbA 1c as a marker of circulating lipids in male and female type 2 diabetic patients. Acta Diabetol 2007; 44: 193-200.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Basit A,
    2. Hydrie MZI,
    3. Hakeem R,
    4. Ahmedani MY,
    5. Waseem M.
    Glycemic control, hypertension and chronic complications in type 2 diabetic subjects attending a tertiary care centre. J Ayub Med Coll Abbottabad 2005; 17: 63-68.
    OpenUrlPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords